<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Choi Y</submitter><funding>NICHD NIH HHS</funding><funding>Markey Cancer Center, University of Kentucky</funding><funding>NIH</funding><pagination>1631-1640</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8354803</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>116(6)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To determine the temporal expression of angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2, in dominant follicles throughout the periovulatory period in women and the regulatory mechanisms underlying ACE2 expression in human granulosa/lutein cells (hGLC).&lt;h4>Design&lt;/h4>Experimental prospective clinical study and laboratory-based investigation.&lt;h4>Setting&lt;/h4>University Medical Center and private in vitro fertilization center.&lt;h4>Patient(s)&lt;/h4>Thirty premenopausal women undergoing surgery for tubal ligation and 16 premenopausal women undergoing in vitro fertilization.&lt;h4>Intervention(s)&lt;/h4>Administration of human chorionic gonadotropin (hCG) and harvesting of preovulatory/ovulatory follicles by timed laparoscopy, and collection of granulosa/lutein cells an</pubmed_abstract><journal>Fertility and sterility</journal><pubmed_title>Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary.</pubmed_title><pmcid>PMC8354803</pmcid><funding_grant_id>R03 HD095098</funding_grant_id><funding_grant_id>P30CA177558</funding_grant_id><funding_grant_id>R01HD096077</funding_grant_id><funding_grant_id>P01 HD071875</funding_grant_id><funding_grant_id>P01HD71875</funding_grant_id><funding_grant_id>R01 HD096077</funding_grant_id><funding_grant_id>R03HD095098</funding_grant_id><pubmed_authors>Brannstrom M</pubmed_authors><pubmed_authors>Jo M</pubmed_authors><pubmed_authors>Curry TE</pubmed_authors><pubmed_authors>Choi Y</pubmed_authors><pubmed_authors>Jeon H</pubmed_authors><pubmed_authors>Akin JW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary.</name><description>&lt;h4>Objective&lt;/h4>To determine the temporal expression of angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2, in dominant follicles throughout the periovulatory period in women and the regulatory mechanisms underlying ACE2 expression in human granulosa/lutein cells (hGLC).&lt;h4>Design&lt;/h4>Experimental prospective clinical study and laboratory-based investigation.&lt;h4>Setting&lt;/h4>University Medical Center and private in vitro fertilization center.&lt;h4>Patient(s)&lt;/h4>Thirty premenopausal women undergoing surgery for tubal ligation and 16 premenopausal women undergoing in vitro fertilization.&lt;h4>Intervention(s)&lt;/h4>Administration of human chorionic gonadotropin (hCG) and harvesting of preovulatory/ovulatory follicles by timed laparoscopy, and collection of granulosa/lutein cells an</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-05-29T19:05:25.926Z</modification><creation>2022-02-11T13:19:21.477Z</creation></dates><accession>S-EPMC8354803</accession><cross_references><pubmed>34538460</pubmed><doi>10.1016/j.fertnstert.2021.08.009</doi></cross_references></HashMap>